Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/06/22
End: 11/05/23
Due: 11/05/24
Phase: N/A
Priority: Normal
Start: 08/06/18
End: 02/03/21
Due: 02/03/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Polymorphisms in ENAM, AMBN, and KLK4 Contribute to DCS. | NCT06343766 | Amina Fouad Farag | user2@example.com | None | 2022-11-06 | 2023-11-05 | 2024-11-05 | - | - | 2025-07-14 |
| Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours | NCT04907422 | Amina Fouad Farag | user2@example.com | None | 2018-08-06 | 2021-02-03 | 2022-02-03 | - | - | 2025-07-14 |